Related Experiment Video
Updated: Jul 26, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Chronic Obstructive Pulmonary Disease: Diagnosis and Management
Stephen D Cagle1, LaTraia S Landrum1, Anne Marie Kennedy1
1Offutt Family Medicine Residency Program, Offutt Air Force Base, Nebraska.
Chronic obstructive pulmonary disease (COPD) management involves spirometry diagnosis and tailored treatments. Pulmonary rehabilitation and specific medications improve quality of life and reduce exacerbations in COPD patients.
Area of Science:
- Pulmonology
- Respiratory Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) affects approximately 6% of the US population.
- Screening asymptomatic adults is not recommended; diagnosis requires spirometry.
- Treatment goals include improving quality of life, reducing exacerbations, and decreasing mortality.
Purpose of the Study:
- To outline current recommendations for COPD diagnosis and management.
- To detail treatment strategies based on disease severity and symptoms.
- To review the efficacy and risks of various therapeutic interventions.
Main Methods:
- Diagnosis confirmed via spirometry.
- Treatment guided by spirometry results and symptom assessment.
- Evaluation of pharmacological and non-pharmacological interventions.
Main Results:
- Pulmonary rehabilitation improves lung function and reduces exacerbations in severe COPD.
- Pharmacological treatment escalates from monotherapy (long-acting muscarinic antagonist) to dual (LAMA/LABA) or triple therapy (LAMA/LABA/ICS) based on symptom control.
- Triple therapy offers greater benefits but increases pneumonia risk.
- Long-term oxygen therapy improves mortality in hypoxemic patients.
- Lung volume reduction surgery improves survival in severe COPD; lung transplant improves quality of life.
Conclusions:
- COPD management requires accurate diagnosis and individualized treatment plans.
- Therapeutic choices range from pulmonary rehabilitation and pharmacotherapy to surgical interventions.
- Treatment efficacy must be balanced against potential risks, such as increased pneumonia risk with triple therapy.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

